We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBVT
10476
CALL
DBV Technologies
DBVT
$873M
$44K ﹤0.01%
+1,690
New +$37.4K
DXF
10477
Eason Technology Ltd
DXF
$1.65M
$44K ﹤0.01%
+26
New +$40.8K
PXJ icon
10478
Invesco Oil & Gas Services ETF
PXJ
$67M
$44K ﹤0.01%
3,044
-24,417
-89% -$300K
SD icon
10479
PUT
SandRidge Energy
SD
$518M
$44K ﹤0.01%
+14,100
New +$34.6K
AEY
10480
DELISTED
ADDvantage Technologies Group
AEY
$44K ﹤0.01%
1,487
-2,645
-64% -$67.3K
ALSK
10481
DELISTED
Alaska Communications Systems
ALSK
$44K ﹤0.01%
11,937
-11,863
-50% -$33.8K
CATX icon
10482
Perspective Therapeutics
CATX
$356M
$43K ﹤0.01%
9,491
+3,554
+60% +$15.7K
ENVB icon
10483
Enveric Biosciences
ENVB
$5.84M
$43K ﹤0.01%
+1
New +$52.5K
GALT icon
10484
Galectin Therapeutics
GALT
$347M
$43K ﹤0.01%
+19,333
New +$50.7K
TEF
10485
PUT
DELISTED
Telefonica
TEF
$43K ﹤0.01%
+12,043
New +$40.7K
TRVG
10486
PUT
trivago
TRVG
$358M
$43K ﹤0.01%
+3,560
New +$31.3K
ENZ
10487
CALL
DELISTED
Enzo Biochem, Inc.
ENZ
$43K ﹤0.01%
17,100
+6,800
+66% +$14.8K
ENSV
10488
DELISTED
Enservco Corp.
ENSV
$43K ﹤0.01%
23,019
+10,744
+88% +$22.2K
OSG
10489
DELISTED
Overseas Shipholding Group Inc.
OSG
$43K ﹤0.01%
+20,088
New +$41.9K
DYNT
10490
DELISTED
Dynatronics Corp
DYNT
$43K ﹤0.01%
10,617
+5,166
+95% +$18.3K
HALL
10491
DELISTED
Hallmark Financial Services, Inc.
HALL
$43K ﹤0.01%
+1,215
New +$37.9K
ACER
10492
DELISTED
Acer Therapeutics Inc
ACER
$43K ﹤0.01%
+16,511
New +$44.4K
WEI
10493
DELISTED
Weidai Ltd. American depositary shares, each representing five (5) Class A ordinary shares
WEI
$43K ﹤0.01%
+6,411
New +$49.7K
ATOS icon
10494
Atossa Therapeutics
ATOS
$26.3M
$42K ﹤0.01%
2,916
+1,281
+78% +$29.7K
DBVT
10495
DBV Technologies
DBVT
$873M
$42K ﹤0.01%
+1,606
New +$35.6K
TOUR
10496
CALL
Tuniu
TOUR
$54.1M
$42K ﹤0.01%
2,360
+330
+16% +$5.46K
NURO
10497
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$42K ﹤0.01%
+1,674
New +$27.5K
STON
10498
DELISTED
StoneMor Inc.
STON
$42K ﹤0.01%
16,153
-5,100
-24% -$6.72K
AUTO
10499
CALL
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$42K ﹤0.01%
+17,100
New +$52.9K
GMLP
10500
DELISTED
Golar LNG Partners LP
GMLP
$42K ﹤0.01%
+16,229
New +$38.6K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.